Preview

Современная ревматология

Расширенный поиск

Опыт применения ингибитора ИЛ 1ß (анакинра) у пациента с CINCA/NOMID-синдромом

https://doi.org/10.14412/1996-7012-2012-749

Полный текст:

Литература

1. <div><p>Кузьмина Н.Н., Салугина С.О., Федоров Е.С. Аутовоспалительные заболевания/синдромы у детей. Учебно-методическое пособие. М.: ИМА-ПРЕСС, 2012; 104 с.</p><p>Федоров Е.С., Салугина С.О., Кузьмина Н.Н. Криопирин-ассоциированные периодические синдромы - мультидисциплинарная проблема современной медицины. Доктор.Ру 2011; 7(66): 58-65.</p><p>Kuijk L.M., Hoffman H.L., Neven B. et al. Episodic Autoinflammatory Disorders in Children. In: Handbook of Systemic Autoimmune Disease. V. 6. Pediatrics in Systemic Autoimmune Disease. R. Cimas, T. Lehman (eds). Elsevier, 2008; 119-135.</p><p>Feldman J., Prieur A.-M., Quartier P. et al. Chronic infantile neurological cutaneouse and articular syndrome is caused by mutations in CIAS1, a gene highly expressed in polymorphonucleare cells and chondrocytes. Am J Hum Genet 2002; 71: 198-203.</p><p>Hoffman H.M., Mueller J.L., Broide D.H. et al. Mutation of a new gene encoding a putative pyrine-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome. Nat Genet 2001; 29: 915-21.</p><p>Neven B., Callebaut I., Prieure A.-M. Molecular basis of the spectral expression of CIAS1 mutations assotiated with phagocytic cell-mediated autoinflammatory disorders CINCA/NOMID, MWS and FCU. Blood 2004; 103: 2809-15.</p><p>Cuisset L., Jeru I., Dumont B. et al. and the French CAPS study group. Mutation in the autoinflammatory cryopyrin-associated periodic syndrome gene: epidemiological study and lessons from eight years of genetic analysis in France. Ann Rheum Dis 2011; 70: 495-9.</p><p>Aksentijevich I., Putnam C.D., Remmers E.F. et al. The clinical continuum of cryopyrinopathies: novel CIAS1 mutations in North American patients and a new cryopyrin model. Arthr Rheum 2007; 56: 1273-85.</p><p>Manji G.A., Wang L., Geddes B.J. et al. PYPAF1, a PYRYN-containing Apaf-like protein that assembles with ASC and regulated activation of NF-kappaB. J Biol Chem 2002; 277: 11570-5.</p><p>Ozen S., Frenkel J., Ruperto N. et al. The Eurofever Project: towards better care for autoinflammatory diseases. Eur J Pediatr 2011; 170(4): 445-52.</p><p>Naselli A., Frenkel J., Ozen S. et al. The EUROFEVER registry for autoinflammatory disease: update on enrollment after 2 years. Ann Rheum Dis 2012; 71(Suppl. 3): 114.</p><p>Prieur A.M. CINCA syndrome. Orphanet Encyclopedia, 2003.</p><p>Toker O., Hashkes P.J. Critical appraisal of canakinumab in the treatment of adults and children with cryopyrin-associated periodic syndrome (CAPS). Biologics: Targets &amp; Therapy 2010; 4: 131-8.</p><p>Yu J.R., Leslie K.S. Cryopyrin-Associated Periodic Syndrome: An Update on Diagnosis and Treatment Response. Curr Allergy Asthma Rep 2011; 11(1): 12—20.</p><p>Lorber J. Syndrome for diagnosis: dwarfing, persistently open fontanelle; recurrent meningitis; recurrent subdural effusions with temporary alternate-sided hemiplegia; high-tone deafness; visual defect with pseudopapilloedema; slowing intellectual development; recurrent acute polyarthritis; erythema marginatum, splenomegaly and iron-resistant hypochromic anaemia. Proc R Soc Med 1973; 66(11): 1070—1.</p><p>Barron K., Athreya B., Kastner D. Periodic fever syndromes and other inherited autoinflammatory diseases in: Textbook of pediatric rheumatology. Ed. by J.T. Cassidy et al. 6th ed. Elsevier Saunders, 2011; 642—60.</p><p>Prieur A.M., Griscelli G. Arthropathy with rash, chronic meningitis, eye lesions and mental retardation. J Pediatr 1981; 99: 79-83.</p><p>Prier A.M., Griscelli G., Lampert F. et al. A chronic, infantile, neurological, cutaneous and articular (CINCA) syndrome, a specific entity analised in 30 patients, Scand J Rheum 1987; 66: 57-68.</p><p>Hassink S.G., Goldsmith D.P. Neonatal onset multisystem inflammatory disease. Arthr Rheum 1983; 26: 668-73.</p><p>Huttenlocher A., Frieden I.J., Emery H. Neonatal onset multisystem inflammatory disease. J Rheum 1995; 22(6): 1171—3.</p><p>Kilcline C., Shinkai K., Bree A. et al. Neonatal-Onset Multisystem Inflammatory Disorder: The Emerging Role of Pyrin Genes in Autoinflammatory Diseases. Arch Dermatol 2005; 141(2): 248-53.</p><p>Aksentijevich I., Nowak M., Mallah M. et al. De novo CIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal-onset multisystem inflammatory disease (NOMID): a new member of the expanding family of pyrin-associated autoinflammatory diseases. Arthr Rheum 2002; 46: 3340-8.</p><p>Prier A.M. A recently recognized chronic inflammatory disease of early onset characterized by the triad of rash, central nervous system involvement and arthropathy. Clin Exp Rheum 2001; 19: 103-6.</p><p>Woo P., Laxer R.M., Sherry D.D. Pediatric Rheumatology in clinical practice. Springer, 2007; 123—36.</p><p>Grateau G. Clinical and genetic aspects of the hereditary periodic fever syndromes. Rheumatology 2004; 43: 410-5.</p><p>Shinkai K., McCalmont T.H., Leslie K.S. Cryopyrin-assotiated periodic syndrome and autoinflammation. Clin Exp Dermatol 2007; 33: 1—9.</p><p>Federico G., Rigante D., Pugliese A.L. et al. Etanercept induces improvement of arthropathy in chronic infantile neurological cutaneous articular (CINCA) syndrome. Scand J Rheum 2003; 32: 312-4.</p><p>Lovell D.J., Bowyer S.L., Solinger A.M. Interleukine-1 Blockade by Anakinra Improves Clinical Symptoms in Patients With Neonatal-Onset Mutisystem Inflammatory Disease. Arthr Rheum 2005; 52: 1283—6.</p><p>Rigante D., Ansuinii V., Caldarelli M. et al. Hydrocephalus in CINCA syndrome treated with anakinra. Childs Nerv Syst 2006; 22: 334—7.</p><p>Frenkel J., Wulffratt N.M., Kuis W. Anakinra in mutation-negative NOMID/CINCA syndrome: comment on the articles by Hawkins et al. and Hoffman and Patel. Arthr Rheum 2004; 50: 3738-9.</p><p>Goldbach-Mansky R., Daily N.J., Canna S.W. et al. Neonatal-Onset Mutisystem Inflammatory Disease Responsive to Interleukine-1 Inhibition. New Engl J Med 2006; 355: 581-92.</p><p>Granel B., Serratrice J., Disdier P. et al. Dramatic improvement with anakinra in a case of chronic infantile neurological cutaneous and articular (CINCA) syndrome. Rheumatology (Oxford) 2005; 44: 689-90.</p><p>Hawkins P.L., Lachmann H.J., McDermott M.F. Interleikin-1 receptor antagonist in the Muckle-Wells syndrome. N Engl J Med 2003; 348: 2583-4.</p><p>Ramos E., Arostegui J.I., Campuzano S. et al. Positive clinical and biochemical responses to anakinra in a 3-yr-old patient with cryopyrin-associated periodic syndrome (CAPS). Rheumatology (Oxford) 2005; 44(8): 1072—3.</p><p>Boschan C., Witt O., Lohse P. et al. Neonatal-onset multisystem inflammatory disease (NOMID) due to a novel S331R mutation of the CIAS1 gene and response to interleukin-1 receptor antagonist treatment. Am J Med Genet A 2006; 140(8): 883-6.</p><p>Paul S.M., Hildenbrand H., Jain M.S. et al. Functional outcomes of one year of treatment of neonatal-onset multisystem inflammatory disease (NOMID) with Anakinra [abstract]. Arthr Rheum 2007; 56(Suppl.): 291.</p><p>Leslie K.S., Lachmann H.J., Bruning E. et al. Phenotype, Genotype, and Sustained Response to Anakinra in 22 Patients With Autoinflammatory Disease Associated With CIAS-1/NALP3 Mutations. Arch Dermatol 2006; 142: 1591-7.</p><p>Neven B., Marvillet I., Terrada C. et al. Long-term efficacy of the interleukin-1 receptor antagonist anakinra in ten patients with neonatal-onset multisystem inflammatory disease/ chronic infantile neurologic, cutaneous, articular syndrome. Arthr Rheum 2010; 62: 258—67.</p><p>Terrada C., Neven B., Boddaert N. et al. Ocular modifications in a young girl with cryopyrin-associated periodic syndromes responding to interleukin-1 receptor antagonist anakinra. J Ophthal Inflamm Infect 2011; 1: 133—6.</p><p>Haar N., Lachmann H., Ozen S. et al. Treatment of autoinflammatory diseases: results from the Eurofever registry and a literature review. Ann Rheum Dis online on July 2012.</p><p>Miyamae T., Inaba Y., Nishimura G. et al. Effect of anakinra on arthropathy in CINCA/ NOMID syndrome. Pediatric Rheum 2001; 8: 9.</p></div><br />


Для цитирования:


Салугина С.О., Федоров Е.С., Кузьмина Н.Н. Опыт применения ингибитора ИЛ 1ß (анакинра) у пациента с CINCA/NOMID-синдромом. Современная ревматология. 2012;6(3):60-65. https://doi.org/10.14412/1996-7012-2012-749

For citation:


Salugina S.O., Fedorov E.S., Kuzmina N.N. Experience with an IL-1ß inhibitor (anakinra) in a patient with CINCA/NOMID syndrome. Modern Rheumatology Journal. 2012;6(3):60-65. (In Russ.) https://doi.org/10.14412/1996-7012-2012-749

Просмотров: 519


Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.


ISSN 1996-7012 (Print)
ISSN 2310-158X (Online)